Pexacerfont

CAS: 459856-18-9

Ref. 3D-FP170137

Información del producto

• Nombre: Pexacerfont
• Sinónimos: BMS 562086, 8-(6-Methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]pyrazolo[1,5-a]-1,3,5-triazin-4-amine, Pyrazolo[1,5-a]-1,3,5-triazin-4-amine, 8-(6-methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]-

Descripción

Pexacerfont is an experimental drug that has been used as a model to study the pharmacokinetic properties of drugs. It has been shown to be an antagonist of gamma-aminobutyric acid (GABA), and this may be due to its ability to inhibit the binding of GABA to its receptors. Pexacerfont has also been shown to have pharmacological effects in humans, such as improving locomotor activity and reducing symptoms of anxiety. Pexacerfont is not toxic in animal studies, but it is unclear if these results are clinically relevant.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 340.42 g/mol
• Fórmula: C₁₈H₂₄N₆O
• Pureza: Min. 98 Area-%
• Color/Forma: Powder
• InChI: InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1
• Clave InChI: InChIKey=LBWQSAZEYIZZCE-SNVBAGLBSA-N
• SMILES: CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12